Evidence map›Paper›PMID 39317446›Full record

ReviewBritish journal of pharmacology2024

Contribution of hypothalamic orexin (hypocretin) circuits to pathologies of motivation.

Aida Mohammadkhani, Caitlin Mitchell, Morgan H James, Stephanie L Borgland, Christopher V Dayas

Abstract readReview
In one paragraph

Review in British journal of pharmacology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Review
  4. Article
  5. Review
  6. Review
  7. Article
  8. Sleep-Related Eating Disorder and Sexsomnia; Two Rare Parasomnias? A Mini-Review with Illustrative Case-Reports.International journal of sexual health : official journal of the World Association for Sexual Health · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Aida MohammadkhaniDepartment of Physiology and Pharmacology, Hotchkiss Brain Institute, The University of Calgary, Calgary, Alberta, Canada.
Caitlin MitchellSchool of Biomedical Sciences and Pharmacy, University of Newcastle, University Drive, Callaghan, New South Wales, Australia.
Morgan H JamesDepartment of Psychiatry and Brain Health Institute, Robert Wood Johnson Medical School, Rutgers University, Piscataway, New Jersey, USA.
Stephanie L BorglandDepartment of Physiology and Pharmacology, Hotchkiss Brain Institute, The University of Calgary, Calgary, Alberta, Canada.
Christopher V DayasSchool of Biomedical Sciences and Pharmacy, University of Newcastle, University Drive, Callaghan, New South Wales, Australia.

Funding

Translational Research Support CoreP30ES005022 · NIEHS · UNIV OF MED/DENT NJ-R W JOHNSON MED SCH · PI BRIAN T BUCKLEY · 1988 to 2026
$47.4M
ROLE OF OREXIN IN COCAINE DEMAND AND ADDICTIONR01DA006214 · NIDA · UNIVERSITY OF PENNSYLVANIA · PI ASTON-JONES, GARY S. · 1989 to 2024
$6.0M
Rutgers Optimizes Innovation (ROI) ProgramU01HL150852 · NHLBI · RUTGERS BIOMEDICAL/HEALTH SCIENCES-RBHS · PI LIBUTTI, STEVEN K., PANETTIERI, REYNOLD ALEXANDER · 2019 to 2022
$4.4M
Orexin (hypocretin) signaling in ventral tegmental area as a common mediator of sleep disturbances and drug demand in cocaine abstinenceR01DA061303 · NIDA · RUTGERS BIOMEDICAL AND HEALTH SCIENCES · PI Gary S. Aston-Jones, Morgan H. James · 2024 to 2026
$1.1M
Orexin/hypocretin as a common mediator of stress and reward behavior in cocaine addictionR00DA045765 · NIDA · RUTGERS BIOMEDICAL AND HEALTH SCIENCES · PI JAMES, MORGAN H. · 2021 to 2023
$747k
The orexin system as a novel mediator of depression-like outcomes in female rats exposed to an endocrine disrupting compound during the peripubertal periodR21ES035848 · NIEHS · RUTGERS BIOMEDICAL AND HEALTH SCIENCES · PI JAMES, MORGAN H., ROEPKE, TROY ADAM · 2024 to 2025
$432k
Canada Research Chair 950-232211Hunter Medical Research InstituteMathison Centre for Research and Education Postdoctoral FellowshipNational Health and Medical Research Council of Australia GNT1125478National Health and Medical Research Council of Australia GNT1165679National Heart Brain and Lung Institute U01HL 150852New Jersey Health Foundation PC144-23New Jersey Health Foundation PC98-22NHLBI NIH HHS U01 HL150852NIDA NIH HHS R00 DA045765NIDA NIH HHS R00DA 045765NIDA NIH HHS R01 DA006214NIDA NIH HHS R01 DA061303NIDA NIH HHS R01DA061303NIEHS NIH HHS P30 ES005022NIEHS NIH HHS R21 ES035848NIEHS NIH HHS R21ES 035848NSERC Discovery DG-343012/DAS-04060Rutgers Optimizes Innovation-Health Advance
6 · The paper itself

Abstract

The orexin (also known as hypocretin) system, consisting of neuropeptides orexin-A and orexin-B, was discovered over 25 years ago and was immediately identified as a central regulator of sleep and wakefulness. These peptides interact with two G-protein coupled receptors, orexin 1 (OX

Indexed as

HypothalamusMotivationOrexinsAnimalsHumansNeuropeptidesOrexin ReceptorsNeuropeptidesOrexin ReceptorsOrexinsaddictiondopamineeatingmesolimbic systemnucleus accumbensorexin hypocretinorexin reserveparaventricular nucleusventral tegmental area

Identifiers

PMID39317446
PMCPMC11458361

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.